Early serum (1→3)-β-D-glucan levels in patients with burn injury

Mycoses

Volumn 55, Issue 3, 2012, Pages 224-227

  Shupp, Jeffrey W ^a,b   Petraitiene, Ruta ^e,f   Jaskille, Amin D ^a,b   Pavlovich, Anna R ^a,b   Matt, Sarah E ^a,b   Nguyen, Do T ^c   Kath, Melissa A ^a,b   Jeng, James C ^a,b   Jordan, Marion H ^a,b   Finkelman, Malcolm ^d   Walsh, Thomas J ^e,f   Shoham, Shmuel ^a,b  

^a WASHINGTON HOSPITAL CENTER   (United States)

^b MEDSTAR RESEARCH INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Associates of Cape Cod Inc   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

^f WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Burn wound infection; Diagnosis of candidemia

Indexed keywords

BETA 1,3 GLUCAN;

ARTICLE; BODY SURFACE; BURN; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; GAUZE DRESSING; HEMODIALYSIS; HUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERMAL INJURY;

BETA-GLUCANS; BURNS; CANDIDA; CANDIDEMIA; FEMALE; HUMANS; PROSPECTIVE STUDIES;

EID: 84859960559     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02068.x     Document Type: Article

References (16)

1. Brusselaers N, Monstrey S, Snoeij T et al. Morbidity and mortality of bloodstream infections in patients with severe burn injury. Am J Crit Care 2010; 19: e81-87.
2. Moore EC, Padiglione AA, Wasiak J, Paul E, Cleland H. Candida in burns: risk factors and outcomes. J Burn Care Res, 2010; 31: 257-63.
3. Smith PB, Benjamin DK Jr, Alexander BD, Johnson MD, Finkelman MA, Steinbach WJ. Quantification of 1, 3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol 2007; 14: 924-5.
4. Obayashi T, Yoshida M, Mori T et al. Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet 1995; 345: 17-20.
5. Sendid B, Tabouret M, Poirot JL, Mathieu D, Fruit J, Poulain D. New enzyme immunoassays for sensitive detection of circulating Candida albicans mannan and antimannan antibodies: useful combined test for diagnosis of systemic candidiasis. J Clin Microbiol 1999; 37: 1510-7.
6. Walsh TJ, Merz WG, Lee JW et al. Diagnosis and therapeutic monitoring of invasive candidiasis by rapid enzymatic detection of serum D-arabinitol. Am J Med 1995; 99: 164-72.
7. Yeo SF, Wong B. Current status of nonculture methods for diagnosis of invasive fungal infections. Clin Microbiol Rev 2002; 15: 465-84.
8. Ostrosky-Zeichner L, Alexander BD, Kett DH et al. Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005; 41: 654-9.
9. Digby J, Kalbfleisch J, Glenn A, Larsen A, Browder W, Williams D. Serum glucan levels are not specific for presence of fungal infections in intensive care unit patients. Clin Diagn Lab Immunol 2003; 10: 882-5.
10. Kato A, Takita T, Furuhashi M, Takahashi T, Maruyama Y, Hishida A. Elevation of blood (1-->3)-beta-D-glucan concentrations in hemodialysis patients. Nephron 2001; 89: 15-19.
11. Nakao A, Yasui M, Kawagoe T, Tamura H, Tanaka S, Takagi H. False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis. Hepatogastroenterology 1997; 44: 1413-8.
12. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1->3)-beta-D-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005; 43: 5957-62.
13. Usami M, Ohata A, Horiuchi T, Nagasawa K, Wakabayashi T, Tanaka S. Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing. Transfusion 2002; 42: 1189-95.
14. Odabasi Z, Mattiuzzi G, Estey E et al. Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004; 39: 199-205.
15. Magnotti LJ, Deitch EA. Burns, bacterial translocation, gut barrier function, and failure. J Burn Care Rehabil 2005; 26: 383-91.
16. Mozingo DW, McManus AT, Kim SH, Pruitt BA Jr. Incidence of bacteremia after burn wound manipulation in the early postburn period. J Trauma 1997; 42: 1006-10. discussion 1010-1001.